ADVISORY COMMTTEE FOR PHARMACEUTICAL SCIENCE
September 24, 1999
Slides
Exposure-Response
Introduction/Overview, Roger L Williams, MD, Deputy Center Director for Pharmaceutical
Science, CDER, FDA
Exposure-Response
(PK/PD), Lawrence J. Lesko, PhD, Office of Clinical Pharmacology and Biopharmaceutics,
CDER, FDA
Exposure-Response
Document Expert Panel Review Report, Don Stanski, MD
Drug-Drug Interaction
Introduction, Roger L Williams, MD, Deputy Center Director for Pharmaceutical Science,
CDER, FDA
In Vivo
Drug-Drug Interactions, Shiew-Mei Huang, PhD, Associate Director, Science & Regulatory
Policy, Office of Clinical Pharmacology and Biopharmaceutics, OPS, CDER, FDA
ACPS Nonclinical
Studies Subcommittee
Nonclinical
Studies Subcommittee Report, Jack A. Reynolds, Subcommittee Chairperson